SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,999 | -53.9% | 5,000 | 0.0% | 0.00% | – |
| Q2 2023 | $6,500 | -66.8% | 5,000 | -55.0% | 0.00% | – |
| Q1 2023 | $19,559 | +5.4% | 11,113 | +88.0% | 0.00% | – |
| Q4 2022 | $18,557 | -54.7% | 5,910 | -28.7% | 0.00% | – |
| Q3 2022 | $41,000 | +17.1% | 8,284 | -2.2% | 0.00% | – |
| Q2 2022 | $35,000 | -25.5% | 8,469 | +4.0% | 0.00% | – |
| Q1 2022 | $47,000 | -6.0% | 8,141 | +22.3% | 0.00% | – |
| Q4 2021 | $50,000 | -2.0% | 6,659 | +18.2% | 0.00% | – |
| Q3 2021 | $51,000 | -25.0% | 5,635 | -1.0% | 0.00% | – |
| Q2 2021 | $68,000 | +7.9% | 5,690 | +13.8% | 0.00% | – |
| Q1 2021 | $63,000 | -19.2% | 5,000 | 0.0% | 0.00% | – |
| Q4 2020 | $78,000 | +66.0% | 5,000 | 0.0% | 0.00% | – |
| Q3 2020 | $47,000 | +4.4% | 5,000 | 0.0% | 0.00% | – |
| Q2 2020 | $45,000 | +40.6% | 5,000 | 0.0% | 0.00% | – |
| Q1 2020 | $32,000 | -25.6% | 5,000 | -3.4% | 0.00% | – |
| Q4 2019 | $43,000 | -8.5% | 5,176 | 0.0% | 0.00% | – |
| Q3 2019 | $47,000 | -16.1% | 5,176 | 0.0% | 0.00% | – |
| Q2 2019 | $56,000 | +9.8% | 5,176 | -2.5% | 0.00% | – |
| Q1 2019 | $51,000 | -16.4% | 5,310 | 0.0% | 0.00% | – |
| Q4 2018 | $61,000 | -32.2% | 5,310 | 0.0% | 0.00% | – |
| Q3 2018 | $90,000 | +20.0% | 5,310 | 0.0% | 0.00% | – |
| Q2 2018 | $75,000 | -29.2% | 5,310 | -4.7% | 0.00% | – |
| Q1 2018 | $106,000 | +29.3% | 5,569 | +11.4% | 0.00% | – |
| Q4 2017 | $82,000 | -4.7% | 5,000 | -13.0% | 0.00% | – |
| Q3 2017 | $86,000 | +95.5% | 5,750 | +15.0% | 0.00% | – |
| Q2 2017 | $44,000 | +69.2% | 5,000 | 0.0% | 0.00% | – |
| Q1 2017 | $26,000 | +73.3% | 5,000 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | -34.8% | 5,000 | 0.0% | 0.00% | – |
| Q3 2016 | $23,000 | -20.7% | 5,000 | 0.0% | 0.00% | – |
| Q2 2016 | $29,000 | -3.3% | 5,000 | 0.0% | 0.00% | – |
| Q1 2016 | $30,000 | -34.8% | 5,000 | 0.0% | 0.00% | – |
| Q4 2015 | $46,000 | +64.3% | 5,000 | 0.0% | 0.00% | – |
| Q3 2015 | $28,000 | -49.1% | 5,000 | 0.0% | 0.00% | – |
| Q2 2015 | $55,000 | -29.5% | 5,000 | 0.0% | 0.00% | – |
| Q1 2015 | $78,000 | +2.6% | 5,000 | 0.0% | 0.00% | – |
| Q4 2014 | $76,000 | +40.7% | 5,000 | 0.0% | 0.00% | – |
| Q3 2014 | $54,000 | -28.9% | 5,000 | 0.0% | 0.00% | – |
| Q2 2014 | $76,000 | -15.6% | 5,000 | 0.0% | 0.00% | – |
| Q1 2014 | $90,000 | +30.4% | 5,000 | 0.0% | 0.00% | – |
| Q4 2013 | $69,000 | +32.7% | 5,000 | 0.0% | 0.00% | – |
| Q3 2013 | $52,000 | +33.3% | 5,000 | 0.0% | 0.00% | – |
| Q2 2013 | $39,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 1,539,994 | $11,550,000 | 0.74% |
| Golden State Equity Partners | 143,768 | $1,078,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 765,000 | $5,975,000 | 0.40% |
| WASATCH ADVISORS LP | 10,960,982 | $82,207,000 | 0.34% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $332,000 | 0.32% |
| EMC Capital Management | 61,394 | $460,000 | 0.25% |
| Rokos Capital Management LLP | 539,860 | $4,108,000 | 0.25% |
| Long Focus Capital Management, LLC | 245,000 | $1,838,000 | 0.24% |
| Vanguard Capital Wealth Advisors | 33,380 | $250,000 | 0.18% |
| Fort Sheridan Advisors LLC | 74,898 | $562,000 | 0.16% |